Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus P Machold

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Nature Clinical Practice. Rheumatology|August 9, 2007
Infliximab treatment strategy: dose titration based on response in patients with RAKlaus P Machold
Best Practice & Research. Clinical Rheumatology|June 11, 2010
Prevention and cure of rheumatoid arthritis: is it possible?Klaus P Machold
Expert Opinion on Biological Therapy|March 29, 2003
Adalimumab - a new TNF-alpha antibody for treatment of inflammatory joint diseaseKlaus P Machold, Josef S Smolen
Best Practice & Research. Clinical Rheumatology|December 14, 2004
Therapeutic strategies in early rheumatoid arthritisJosef S Smolen, Daniel Aletaha, Klaus P Machold
Frontiers in Medicine|February 22, 2020
The Supply of Rheumatology Specialist Care in Real Life. Results of a Nationwide Survey and Analysis of Supply and NeedsRudolf Puchner, Anna Vavrovsky, Herwig Pieringer, et al.
Current Opinion in Rheumatology|April 4, 2006
Early rheumatoid arthritisKlaus P Machold, Valerie Nell, Tanja Stamm, et al.
Arthritis Research & Therapy|May 25, 2006
Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?Klaus P Machold, Valerie P K Nell, Tanja A Stamm, et al.
Arthritis and Rheumatism|December 14, 2004
Content comparison of occupation-based instruments in adult rheumatology and musculoskeletal rehabilitation based on the International Classification of Functioning, Disability and HealthTanja A Stamm, Alarcos Cieza, Klaus P Machold, et al.
Arthritis Research & Therapy|March 2, 2006
Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failureTheresa Kapral, Tanja Stamm, Klaus P Machold, et al.
Annals of the Rheumatic Diseases|September 28, 2013
Proposal for a new nomenclature of disease-modifying antirheumatic drugsJosef S Smolen, Désirée van der Heijde, Klaus P Machold, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Nature Clinical Practice. Rheumatology|August 9, 2007
Infliximab treatment strategy: dose titration based on response in patients with RAKlaus P Machold
Best Practice & Research. Clinical Rheumatology|June 11, 2010
Prevention and cure of rheumatoid arthritis: is it possible?Klaus P Machold
Expert Opinion on Biological Therapy|March 29, 2003
Adalimumab - a new TNF-alpha antibody for treatment of inflammatory joint diseaseKlaus P Machold, Josef S Smolen
Best Practice & Research. Clinical Rheumatology|December 14, 2004
Therapeutic strategies in early rheumatoid arthritisJosef S Smolen, Daniel Aletaha, Klaus P Machold
Frontiers in Medicine|February 22, 2020
The Supply of Rheumatology Specialist Care in Real Life. Results of a Nationwide Survey and Analysis of Supply and NeedsRudolf Puchner, Anna Vavrovsky, Herwig Pieringer, et al.
Current Opinion in Rheumatology|April 4, 2006
Early rheumatoid arthritisKlaus P Machold, Valerie Nell, Tanja Stamm, et al.
Arthritis Research & Therapy|May 25, 2006
Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?Klaus P Machold, Valerie P K Nell, Tanja A Stamm, et al.
Arthritis and Rheumatism|December 14, 2004
Content comparison of occupation-based instruments in adult rheumatology and musculoskeletal rehabilitation based on the International Classification of Functioning, Disability and HealthTanja A Stamm, Alarcos Cieza, Klaus P Machold, et al.
Arthritis Research & Therapy|March 2, 2006
Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failureTheresa Kapral, Tanja Stamm, Klaus P Machold, et al.
Annals of the Rheumatic Diseases|September 28, 2013
Proposal for a new nomenclature of disease-modifying antirheumatic drugsJosef S Smolen, Désirée van der Heijde, Klaus P Machold, et al.
Pageof 4